{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:13Z","timestamp":1788304573704,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":52,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_40","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:42:00Z","timestamp":1788302520000},"page":"675-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression and Characterization of Blood Group Binding Lectins"],"prefix":"10.1007","author":[{"given":"Hsien-Ya","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Chuen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau-Ming","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter J.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"40_CR1","volume-title":"\u00dcber Ricin ein giftiges Ferment aus den Samen von Ricinus communis L. und einige anderen Euphorbiaceen","author":"H Stillmark","year":"1888","unstructured":"Stillmark H (1888) \u00dcber Ricin ein giftiges Ferment aus den Samen von Ricinus communis L. und einige anderen Euphorbiaceen. University of Dorpat, Dorpat"},{"issue":"32","key":"40_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1055\/s-0029-1206682","volume":"17","author":"P Ehrlich","year":"1891","unstructured":"Ehrlich P (1891) Experimentelle untersuchungen \u00fcber immunit\u00e4t. I Ueber ricin. Dtsch Med Wochenschr 17(32):976\u2013979","journal-title":"Dtsch Med Wochenschr"},{"key":"40_CR3","unstructured":"Landsteiner K, Raubitschek H (1907) Observations on hemolysis and hemagglutination. C Bakt:45"},{"issue":"1","key":"40_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000460684","volume":"8","author":"WC Boyd","year":"1963","unstructured":"Boyd WC (1963) The lectins: their present status. Vox Sang 8(1):1\u201332","journal-title":"Vox Sang"},{"issue":"3091","key":"40_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.119.3091.419.a","volume":"119","author":"WC Boyd","year":"1954","unstructured":"Boyd WC, Shapleigh E (1954) Specific precipitating activity of plant agglutinins (lectins). Science 119(3091):419","journal-title":"Science"},{"issue":"5","key":"40_CR6","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.3390\/molecules20057637","volume":"20","author":"D Hu","year":"2015","unstructured":"Hu D, Tateno H, Hirabayashi J (2015) Lectin engineering, a molecular evolutionary approach to expanding the lectin utilities. Molecules 20(5):7637\u20137656","journal-title":"Molecules"},{"issue":"8","key":"40_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"FT Liu","year":"2023","unstructured":"Liu FT, Stowell SR (2023) The role of galectins in immunity and infection. Nat Rev Immunol 23(8):479\u2013494","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"40_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00253-010-2892-9","volume":"89","author":"SK Lam","year":"2011","unstructured":"Lam SK, Ng TB (2011) Lectins: production and practical applications. Appl Microbiol Biotechnol 89(1):45\u201355","journal-title":"Appl Microbiol Biotechnol"},{"key":"40_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-0716-2269-8_12","volume":"2487","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao Y, Yong Y (2022) Lectin-mediated coimmobilization of cascade glycoenzymes. Methods Mol Biol 2487:189\u2013195","journal-title":"Methods Mol Biol"},{"issue":"2","key":"40_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/D2CS00736C","volume":"52","author":"M Martinez-Bailen","year":"2023","unstructured":"Martinez-Bailen M, Rojo J, Ramos-Soriano J (2023) Multivalent glycosystems for human lectins. Chem Soc Rev 52(2):536\u2013572","journal-title":"Chem Soc Rev"},{"issue":"3","key":"40_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/glycob\/cwp186","volume":"20","author":"TK Dam","year":"2010","unstructured":"Dam TK, Brewer CF (2010) Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 20(3):270\u2013279","journal-title":"Glycobiology"},{"issue":"1","key":"40_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105798","volume":"26","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) ABO blood group antigens and differential glycan expression: perspective on the evolution of common human enzyme deficiencies. iScience 26(1):105798","journal-title":"iScience"},{"issue":"4","key":"40_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ajt.2022.12.017","volume":"23","author":"A Joseph","year":"2023","unstructured":"Joseph A et al (2023) ABO genotyping finds more A(2) to B kidney transplant opportunities than lectin-based subtyping. Am J Transplant 23(4):512\u2013519","journal-title":"Am J Transplant"},{"issue":"21","key":"40_CR14","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","volume":"2","author":"CL Maier","year":"2018","unstructured":"Maier CL et al (2018) Antibody-mediated immune suppression by antigen modulation is antigen-specific. Blood Adv 2(21):2986\u20133000","journal-title":"Blood Adv"},{"key":"40_CR15","doi-asserted-by":"crossref","unstructured":"Mener A et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22)","DOI":"10.1172\/jci.insight.121631"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","volume":"9","author":"SR Patel","year":"2018","unstructured":"Patel SR et al (2018) Marginal zone B cells induce alloantibody formation following RBC transfusion. Front Immunol 9:2516","journal-title":"Front Immunol"},{"issue":"23","key":"40_CR17","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"9","key":"40_CR18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317","journal-title":"Blood"},{"issue":"3","key":"40_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL et al (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica 105(3):539\u2013544","journal-title":"Haematologica"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL et al (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica 105:539","journal-title":"Haematologica"},{"issue":"2","key":"40_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM et al (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5(2):527\u2013538","journal-title":"Blood Adv"},{"issue":"21","key":"40_CR22","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653","journal-title":"Blood"},{"issue":"1","key":"40_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1182\/asheducation-2016.1.452","volume":"2016","author":"JC Zimring","year":"2016","unstructured":"Zimring JC, Hudson KE (2016) Cellular immune responses in red blood cell alloimmunization. Hematol Am Soc Hematol Educ Program 2016(1):452\u2013456","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"40_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOH.0000000000000540","volume":"26","author":"KE Hudson","year":"2019","unstructured":"Hudson KE et al (2019) Mechanisms of alloimmunization in sickle cell disease. Curr Opin Hematol 26(6):434\u2013441","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"40_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098","journal-title":"Blood"},{"key":"40_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A et al (2021) Antibodies to low-copy number RBC alloantigen convert a tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol 12:629608","journal-title":"Front Immunol"},{"issue":"5","key":"40_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/trf.16872","volume":"62","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion 62(5):948\u2013953","journal-title":"Transfusion"},{"issue":"8","key":"40_CR28","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122(8):1494\u20131504","journal-title":"Blood"},{"issue":"10","key":"40_CR29","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","volume":"191","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation. J Immunol 191(10):5013\u20135025","journal-title":"J Immunol"},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"1548548","DOI":"10.3389\/fimmu.2025.1548548","volume":"16","author":"RP Jajosky","year":"2025","unstructured":"Jajosky RP et al (2025) CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front Immunol 16:1548548","journal-title":"Front Immunol"},{"key":"40_CR31","doi-asserted-by":"publisher","first-page":"1475470","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP et al (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"issue":"7","key":"40_CR32","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1182\/bloodadvances.2019001299","volume":"4","author":"DR Gruber","year":"2020","unstructured":"Gruber DR et al (2020) Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice. Blood Adv 4(7):1526\u20131537","journal-title":"Blood Adv"},{"issue":"4329","key":"40_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/170674a0","volume":"170","author":"GW Bird","year":"1952","unstructured":"Bird GW (1952) Relationship of the blood sub-groups A1, A2 and A1B, A2B to haemagglutinins present in the seeds of Dolichos biflorus. Nature 170(4329):674","journal-title":"Nature"},{"issue":"807","key":"40_CR34","doi-asserted-by":"publisher","first-page":"eadl4922","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S et al (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17(807):eadl4922","journal-title":"Sci Transl Med"},{"issue":"5","key":"40_CR35","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bjh.13339","volume":"169","author":"JB Vidler","year":"2015","unstructured":"Vidler JB et al (2015) Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol 169(5):746\u2013753","journal-title":"Br J Haematol"},{"issue":"6","key":"40_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/bjh.13494","volume":"170","author":"K Gardner","year":"2015","unstructured":"Gardner K et al (2015) How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease. Br J Haematol 170(6):745\u2013756","journal-title":"Br J Haematol"},{"issue":"10","key":"40_CR37","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajh.24460","volume":"91","author":"A Habibi","year":"2016","unstructured":"Habibi A et al (2016) Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes. Am J Hematol 91(10):989\u2013994","journal-title":"Am J Hematol"},{"issue":"3","key":"40_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/vox.12217","volume":"108","author":"F Noizat-Pirenne","year":"2015","unstructured":"Noizat-Pirenne F et al (2015) The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease. Vox Sang 108(3):262\u2013267","journal-title":"Vox Sang"},{"issue":"8","key":"40_CR39","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","volume":"127","author":"G Dumas","year":"2016","unstructured":"Dumas G et al (2016) Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients. Blood 127(8):1062\u20131064","journal-title":"Blood"},{"issue":"29","key":"40_CR40","doi-asserted-by":"publisher","first-page":"20547","DOI":"10.1074\/jbc.M802495200","volume":"283","author":"SR Stowell","year":"2008","unstructured":"Stowell SR et al (2008) Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 283(29):20547\u201320559","journal-title":"J Biol Chem"},{"issue":"4","key":"40_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101704","volume":"298","author":"AV Blenda","year":"2022","unstructured":"Blenda AV et al (2022) Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. J Biol Chem 298(4):101704","journal-title":"J Biol Chem"},{"issue":"7","key":"40_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104482","volume":"25","author":"SC Wu","year":"2022","unstructured":"Wu SC et al (2022) Innate immune Galectin-7 specifically targets microbes that decorate themselves in blood group-like antigens. iScience 25(7):104482","journal-title":"iScience"},{"issue":"5","key":"40_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100747","volume":"23","author":"HM Jan","year":"2024","unstructured":"Jan HM et al (2024) Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain. Mol Cell Proteomics 23(5):100747","journal-title":"Mol Cell Proteomics"},{"key":"40_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.893185","volume":"9","author":"AD Ho","year":"2022","unstructured":"Ho AD et al (2022) An automated approach to assess relative galectin-glycan affinity following glycan microarray analysis. Front Mol Biosci 9:893185","journal-title":"Front Mol Biosci"},{"key":"40_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2024.101892","volume":"74\u201375","author":"CM Arthur","year":"2024","unstructured":"Arthur CM et al (2024) ABO blood groups and galectins: implications in transfusion medicine and innate immunity. Semin Immunol 74\u201375:101892","journal-title":"Semin Immunol"},{"issue":"1","key":"40_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40364-023-00466-9","volume":"11","author":"D Liu","year":"2023","unstructured":"Liu D, Zhu H, Li C (2023) Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy. Biomark Res 11(1):22","journal-title":"Biomark Res"},{"key":"40_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.110827","volume":"134","author":"A Mishra","year":"2019","unstructured":"Mishra A et al (2019) Structure-function and application of plant lectins in disease biology and immunity. Food Chem Toxicol 134:110827","journal-title":"Food Chem Toxicol"},{"issue":"42","key":"40_CR48","doi-asserted-by":"publisher","first-page":"13837","DOI":"10.1021\/bi990756e","volume":"38","author":"GJ Swaminathan","year":"1999","unstructured":"Swaminathan GJ et al (1999) Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution. Biochemistry 38(42):13837\u201313843","journal-title":"Biochemistry"},{"key":"40_CR49","doi-asserted-by":"publisher","first-page":"29457","DOI":"10.1038\/srep29457","volume":"6","author":"TJ Hsieh","year":"2016","unstructured":"Hsieh TJ et al (2016) Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors. Sci Rep 6:29457","journal-title":"Sci Rep"},{"key":"40_CR50","doi-asserted-by":"crossref","unstructured":"Chan YC et al (2018) Dissecting the structure-activity relationship of galectin-ligand interactions. Int J Mol Sci 19(2)","DOI":"10.3390\/ijms19020392"},{"issue":"5","key":"40_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125946","volume":"10","author":"TJ Hsieh","year":"2015","unstructured":"Hsieh TJ et al (2015) Structural basis underlying the binding preference of human Galectins-1, -3 and -7 for Galbeta1-3\/4GlcNAc. PLoS One 10(5):e0125946","journal-title":"PLoS One"},{"issue":"7\u20139","key":"40_CR52","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1023\/B:GLYC.0000014075.62724.d0","volume":"19","author":"CF Brewer","year":"2002","unstructured":"Brewer CF (2002) Thermodynamic binding studies of galectin-1, -3 and -7. Glycoconj J 19(7\u20139):459\u2013465","journal-title":"Glycoconj J"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:42:02Z","timestamp":1788302522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_40","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}